Racemates & enantiomers in drug research & development:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | Undetermined |
| Veröffentlicht: |
Stockholm
Swedish Pharmaceutical Press
1990
|
| Schriftenreihe: | Acta Pharmaceutica Nordica
2,3 |
| Schlagworte: | |
| Beschreibung: | Literaturangaben |
| Beschreibung: | S. 131 - 229 graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV007690981 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 930421s1990 d||| |||| 10||| und d | ||
| 035 | |a (OCoLC)633973135 | ||
| 035 | |a (DE-599)BVBBV007690981 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-355 | ||
| 245 | 1 | 0 | |a Racemates & enantiomers in drug research & development |c guest ed.: Lars Dalgaard |
| 246 | 1 | 3 | |a Racemates and enantiomers in drug research & development |
| 264 | 1 | |a Stockholm |b Swedish Pharmaceutical Press |c 1990 | |
| 300 | |a S. 131 - 229 |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Acta Pharmaceutica Nordica |v 2,3 | |
| 500 | |a Literaturangaben | ||
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chiralität |g Chemie |0 (DE-588)4147732-7 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Chiralität |g Chemie |0 (DE-588)4147732-7 |D s |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Dalgaard, Lars |e Sonstige |4 oth | |
| 710 | 2 | |a Royal Danish School of Pharmacy |e Sonstige |0 (DE-588)5267776-X |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005047913 | ||
Datensatz im Suchindex
| _version_ | 1804122050757918720 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV007690981 |
| ctrlnum | (OCoLC)633973135 (DE-599)BVBBV007690981 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01276nam a2200361 cb4500</leader><controlfield tag="001">BV007690981</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1990 d||| |||| 10||| und d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)633973135</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007690981</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Racemates & enantiomers in drug research & development</subfield><subfield code="c">guest ed.: Lars Dalgaard</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Racemates and enantiomers in drug research & development</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Stockholm</subfield><subfield code="b">Swedish Pharmaceutical Press</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 131 - 229</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Acta Pharmaceutica Nordica</subfield><subfield code="v">2,3</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chiralität</subfield><subfield code="g">Chemie</subfield><subfield code="0">(DE-588)4147732-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Chiralität</subfield><subfield code="g">Chemie</subfield><subfield code="0">(DE-588)4147732-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dalgaard, Lars</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Royal Danish School of Pharmacy</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5267776-X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005047913</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV007690981 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:07:43Z |
| institution | BVB |
| institution_GND | (DE-588)5267776-X |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005047913 |
| oclc_num | 633973135 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | S. 131 - 229 graph. Darst. |
| publishDate | 1990 |
| publishDateSearch | 1990 |
| publishDateSort | 1990 |
| publisher | Swedish Pharmaceutical Press |
| record_format | marc |
| series2 | Acta Pharmaceutica Nordica |
| spelling | Racemates & enantiomers in drug research & development guest ed.: Lars Dalgaard Racemates and enantiomers in drug research & development Stockholm Swedish Pharmaceutical Press 1990 S. 131 - 229 graph. Darst. txt rdacontent n rdamedia nc rdacarrier Acta Pharmaceutica Nordica 2,3 Literaturangaben Arzneimittel (DE-588)4003115-9 gnd rswk-swf Chiralität Chemie (DE-588)4147732-7 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Chiralität Chemie (DE-588)4147732-7 s Arzneimittel (DE-588)4003115-9 s DE-604 Dalgaard, Lars Sonstige oth Royal Danish School of Pharmacy Sonstige (DE-588)5267776-X oth |
| spellingShingle | Racemates & enantiomers in drug research & development Arzneimittel (DE-588)4003115-9 gnd Chiralität Chemie (DE-588)4147732-7 gnd |
| subject_GND | (DE-588)4003115-9 (DE-588)4147732-7 (DE-588)1071861417 |
| title | Racemates & enantiomers in drug research & development |
| title_alt | Racemates and enantiomers in drug research & development |
| title_auth | Racemates & enantiomers in drug research & development |
| title_exact_search | Racemates & enantiomers in drug research & development |
| title_full | Racemates & enantiomers in drug research & development guest ed.: Lars Dalgaard |
| title_fullStr | Racemates & enantiomers in drug research & development guest ed.: Lars Dalgaard |
| title_full_unstemmed | Racemates & enantiomers in drug research & development guest ed.: Lars Dalgaard |
| title_short | Racemates & enantiomers in drug research & development |
| title_sort | racemates enantiomers in drug research development |
| topic | Arzneimittel (DE-588)4003115-9 gnd Chiralität Chemie (DE-588)4147732-7 gnd |
| topic_facet | Arzneimittel Chiralität Chemie Konferenzschrift |
| work_keys_str_mv | AT dalgaardlars racematesenantiomersindrugresearchdevelopment AT royaldanishschoolofpharmacy racematesenantiomersindrugresearchdevelopment AT dalgaardlars racematesandenantiomersindrugresearchdevelopment AT royaldanishschoolofpharmacy racematesandenantiomersindrugresearchdevelopment |